Arovella Therapeutics Ltd has released a press release.
Prospectus for a Renounceable Pro Rata Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Settlement with HC Berlin Pharma and Rights Issue
- Shareholder Update
- SUDA Expands Patent Coverage For Sildenafil
- SUDA announces update on ZolpiMist in USA and Canada
- SUDA expands dialogue with World Health Organisation
Later from Arovella Therapeutics
- Anagrelide Update
- Business Development Update
- SUDA Achieves TGA GMP Licence
- Request for Trading Halt
- Appendix 4C, Market Update and Top 20
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics